Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela S Shirley

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Human Gene Therapy|August 7, 2002
Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vectorJulie L Andrews, Pamela S Shirley, William O Iverson, et al.
Cancer Gene Therapy|July 3, 2004
Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancerPatricia C Ryan, John L Jakubczak, David A Stewart, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Human Gene Therapy|August 7, 2002
Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vectorJulie L Andrews, Pamela S Shirley, William O Iverson, et al.
Cancer Gene Therapy|July 3, 2004
Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancerPatricia C Ryan, John L Jakubczak, David A Stewart, et al.
Pageof 1